Ugly Hedgehog - Photography Forum
Home Active Topics Newest Pictures Search Login Register
User: Smartdoc
 
Private messages:
Send Private Message

 

User name: Smartdoc
User title (?): none
Currently: offline
Registration date: Jan 7, 2014
Number of topics created: 0
Number of messages posted: 7
Location: Orlando, Florida
Birthday: Sep 22
Feedback (?): 0, positive 0.0%
User's pages: list

About user:
Occupaion: CEO Interests: Health, Photography Biography: Dr. Rudi E. Moerck, Ph.D.,
President & CEO, Valensa International

Rudi joined Valensa in 2005 and led the management team in implementing a new corporate strategy focused on turning the Company into a science-based developer of botanically sourced products and patented formulations for human health and well-being. His responsibilities include the day-to-day operations of the Company and working with his management team to create a strategic vision and focus. Rudi joined Valensa after 27 years of experience in the life sciences industries including being principal inventor of RenaZorb™ a new kidney drug out licensed to Spectrum Pharmaceuticals.
Rudi is an influential thought leader in the nutraceutical industry. In 2010, he began sharing his knowledge on many health and wellness subjects ranging from Eye and Joint Health to Cardiovascular Health, Omega-3 intake and the proper dosing of natural health products, via webinars, videos, speaking appearances and radio, magazine and online interviews. Today, Rudi considers it his mission to help educate and inspire people to live healthier and longer lives through proper nutrition, exercise and supplementation of natural products.
Prior to Valensa, Rudi worked for several public companies including positions as President of Altair Nanotechnologies (ALTI), President of the Pharmaceutical Division of Cambrex (CBM), VP and General Manager of Catalytica Pharmaceuticals and as Vice President of Peroxygens at Degussa AG and Degussa Corporation. He speaks German fluently and has extensive international experience having worked and lived in Switzerland and Germany.
At Catalytica Pharmaceuticals, two years after the acquisition of a Glaxo Welcome site in Greenville, NC for $125 million, Rudi led the team that sold the business for $800 million to DSM. Rudi started a pharmaceutical consulting business and advised Blackstone Group on chemical acquisitions and also worked with FMC Corp. on development of their Bio-products Division.
Rudi holds a BS degree in Biology from Florida Southern College and a Ph.D. from the University of Florida in Organic Chemistry. He was a NIH postdoctoral fellow at Ohio State and taught chemistry at Ohio State and Ohio Wesleyan University. Website: http://www.valensa.com/
 
UglyHedgehog.com - Forum
Copyright 2011-2024 Ugly Hedgehog, Inc.